JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 18, 2006; DOI: 10.1124/jpet.106.112581


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.112581v1
320/1/314    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Turner, J. N.
Right arrow Articles by Raymond, Sr., J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Turner, J. N.
Right arrow Articles by Raymond, Sr., J. R.


Received for publication August 23, 2006.
Revised September 30, 2006.
Accepted for publication October 17, 2006.

Ca2+-calmodulin and Jak2 are Required for Activation of Sodium-proton Exchange by the Gi-coupled 5-hydroxytryptamine1A Receptor

Justin N. Turner 1, Maria N. Garnovskaya 1, Sonya D. Coaxum 1, Tamara M. Vlasova 1, Margarita D. Yakutovich 1, David M. Lefler 1, John Richard Raymond, Sr. 1*

1 Medical University of South Carolina and Ralph H. Johnson VA Medical Center

* Address correspondence to: E-mail: raymondj{at}musc.edu

Abstract

The type I sodium-proton exchanger (NHE-1) is expressed ubiquitously and regulates key cellular functions including mitogenesis, cell volume, and intracellular pH. Despite its importance, the signaling pathways that regulate NHE-1 remain incompletely defined. In this work, we present evidence that stimulation of the 5-hydroxytryptamine1A (5-HT1A) receptor results in the formation of a signaling complex that includes activated Jak2, Ca2+/calmodulin (CaM), and NHE-1, and which involves tyrosine phosphorylation of CaM. The signaling pathway also involves rapid agonist-induced association of CaM and NHE-1 as assessed by co-immunoprecipitation studies, and by bioluminescence resonance energy transfer studies in living cells. We propose that NHE-1 is activated through this pathway: 5-HT1A receptor --> Gi2{alpha} and/or Gi3{alpha} --> Jak2 activation --> tyrosine phosphorylation of CaM --> increased binding of CaM to NHE-1 --> induction of a conformational change in NHE-1 that unmasks an obscured proton-sensing and/or proton transporting region of NHE-1 --> activation of NHE-1. The Gi/o-coupled 5-HT1A receptor now joins a handful of Gq-coupled receptors and hypertonic shock as upstream activators of this emerging pathway. In the course of this work, we have presented clear evidence that CaM can be activated through tyrosine phosphorylation in the absence of a significant role for elevated intracellular Ca2+. We have also demonstrated for the first time that the association of CaM with NHE-1 in living cells is a dynamic process.


Key words: Janus kinase, calcium, calmodulin, proton, serotonin receptor, signal transduction





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.